Zurich Cantonal Bank’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $482K | Buy |
+6,695
| New | +$381K | ﹤0.01% | 1853 |
|
|
2023
Q2 | – | Sell |
-2,250
| Closed | -$23.7K | – | 2835 |
|
|
2023
Q1 | $23.7K | Hold |
2,250
| – | – | ﹤0.01% | 2727 |
|
|
2022
Q4 | $76.3K | Buy |
2,250
+589
| +35% | +$28.5K | ﹤0.01% | 2436 |
|
|
2022
Q3 | $80K | Hold |
1,661
| – | – | ﹤0.01% | 2380 |
|
|
2022
Q2 | $95K | Hold |
1,661
| – | – | ﹤0.01% | 2284 |
|
|
2022
Q1 | $134K | Sell |
1,661
-241
| -13% | -$35.7K | ﹤0.01% | 2138 |
|
|
2021
Q4 | $385K | Buy |
1,902
+659
| +53% | +$143K | ﹤0.01% | 1648 |
|
|
2021
Q3 | $335K | Hold |
1,243
| – | – | ﹤0.01% | 1561 |
|
|
2021
Q2 | $320K | Hold |
1,243
| – | – | ﹤0.01% | 1501 |
|
|
2021
Q1 | $373K | Sell |
1,243
-227
| -15% | -$70.7K | ﹤0.01% | 1401 |
|
|
2020
Q4 | $375K | Buy |
1,470
+145
| +11% | +$37.5K | ﹤0.01% | 1438 |
|
|
2020
Q3 | $330K | Hold |
1,325
| – | – | ﹤0.01% | 1291 |
|
|
2020
Q2 | $460K | Buy |
1,325
+262
| +25% | +$81.8K | ﹤0.01% | 1048 |
|
|
2020
Q1 | $285K | Buy |
1,063
+227
| +27% | +$70.2K | ﹤0.01% | 1061 |
|
|
2019
Q4 | $271K | Sell |
836
-1,679
| -67% | -$487K | ﹤0.01% | 1174 |
|
|
2019
Q3 | $687K | Hold |
2,515
| – | – | 0.01% | 855 |
|
|
2019
Q2 | $1.34M | Sell |
2,515
-75
| -3% | -$37.6K | 0.01% | 749 |
|
|
2019
Q1 | $1.3M | Buy |
2,590
+156
| +6% | +$92.4K | 0.01% | 727 |
|
|
2018
Q4 | $1.2M | Buy |
2,434
+99
| +4% | +$59.8K | 0.01% | 723 |
|
|
2018
Q3 | $2.13M | Hold |
2,335
| – | – | 0.02% | 644 |
|
|
2018
Q2 | $1.71M | Buy |
2,335
+1,616
| +225% | +$1.86M | 0.02% | 694 |
|
|
2018
Q1 | $1.15M | Buy |
719
+120
| +20% | +$155K | 0.01% | 755 |
|
|
2017
Q4 | $536K | Buy |
599
+225
| +60% | +$133K | ﹤0.01% | 856 |
|
|
2017
Q3 | $134K | Hold |
374
| – | – | ﹤0.01% | 1224 |
|
|
2017
Q2 | $110K | Buy |
374
+47
| +14% | +$13.6K | ﹤0.01% | 1312 |
|
|
2017
Q1 | $115K | Hold |
327
| – | – | ﹤0.01% | 1252 |
|
|
2016
Q4 | $60K | Hold |
327
| – | – | ﹤0.01% | 1595 |
|
|
2016
Q3 | $84K | Buy |
327
+35
| +12% | +$9.01K | ﹤0.01% | 1368 |
|
|
2016
Q2 | $62K | Hold |
292
| – | – | ﹤0.01% | 1400 |
|
|
2016
Q1 | $60K | Hold |
292
| – | – | ﹤0.01% | 1362 |
|
|
2015
Q4 | $74K | Buy |
292
+196
| +204% | +$40.3K | ﹤0.01% | 1256 |
|
|
2015
Q3 | $16K | Buy |
96
+63
| +191% | +$11.1K | ﹤0.01% | 1603 |
|
|
2015
Q2 | $6K | Hold |
33
| – | – | ﹤0.01% | 1779 |
|
|
2015
Q1 | $5K | Buy |
+33
| New | +$6.78K | ﹤0.01% | 1902 |
|
|
2014
Q1 | – | Sell |
-3,333
| Closed | -$568K | – | 994 |
|
|
2013
Q4 | $568K | Hold |
3,333
| – | – | 0.02% | 603 |
|
|
2013
Q3 | $523K | Sell |
3,333
-334
| -9% | -$61.7K | 0.02% | 587 |
|
|
2013
Q2 | $635K | Buy |
+3,667
| New | +$562K | 0.02% | 526 |
|
Other funds holding NKTR
BI
TSC
VCM
PM
AC
Zurich Cantonal Bank's NKTR Position: Q1 2026 in Review
Zurich Cantonal Bank opened a new position in Nektar Therapeutics (NKTR) in Q1 2026: 6,695 shares worth $482K. The stake represents ﹤0.01% of the portfolio and ranks #1853 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in NKTR as recently as Q1 2023.
Zurich Cantonal Bank first reported a position in NKTR in Q2 2013 and has held it in 37 quarters since. The position peaked at $2.13M in Q3 2018. 215 funds tracked by Wall St. Rank hold NKTR as of Q1 2026.
- Zurich Cantonal Bank held 6,695 shares of Nektar Therapeutics worth $482K as of Q1 2026.
- Nektar Therapeutics was a new Zurich Cantonal Bank position in Q1 2026.
- Nektar Therapeutics made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #1853 holding.
- Zurich Cantonal Bank first reported a position in Nektar Therapeutics in Q2 2013 and has held it in 37 quarters since.
- Zurich Cantonal Bank's Nektar Therapeutics position peaked at $2.13M in Q3 2018.
- 215 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2026.
Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.